Insulin sensitivity in people born pre-term, with low or very low birth weight and small for gestational age

P L Hofman1, W S Cutfield

  • 1Liggins Institute, University of Auckland, Auckland, New Zealand. p.hofman@auckland.ac.nz

Insights

Children born small for gestational age (SGA) face long-term health risks like obesity and diabetes due to reduced insulin sensitivity. Premature infants may experience similar insulin resistance and health issues, highlighting the importance of early life environments.

Area of Science:

  • Pediatrics
  • Endocrinology
  • Developmental Biology

Background:

  • Small for gestational age (SGA) children exhibit increased risks for adult obesity, type 2 diabetes mellitus, hypertension, coronary artery disease, and stroke.
  • This heightened risk is associated with persistent early-life reduction in insulin sensitivity.
  • Prematurity, like being born SGA at term, may also induce insulin resistance and similar long-term health consequences.

Purpose of the Study:

  • To explore the parallels between term SGA and premature infants regarding insulin sensitivity and long-term health outcomes.
  • To investigate the potential role of maternal factors and the intrauterine environment in influencing insulin sensitivity in these populations.
  • To hypothesize that early neonatal interventions in premature infants could normalize insulin sensitivity.

Main Methods:

  • Comparative analysis of existing evidence on term SGA and premature infants.
  • Examination of the impact of intrauterine and early postnatal environments.
  • Review of potential pathophysiological mechanisms linking early life factors to insulin sensitivity.

Main Results:

  • Both term SGA and premature birth create abnormal early life environments (intrauterine and postnatal).
  • Maternal factors and the intrauterine milieu, including nutrient supply, are crucial.
  • Prematurity is hypothesized to lead to insulin resistance with potentially similar health consequences as being born SGA.

Conclusions:

  • Prematurity may share similar long-term health risks with term SGA infants due to insulin resistance.
  • Early manipulation of nutritional and environmental factors in premature neonates warrants investigation for potential normalization of insulin sensitivity.
  • Further research is essential to elucidate the mechanisms of reduced insulin sensitivity and confirm the long-term health links in premature infants.

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...